Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Patient demographics

From: Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST

Age range (median) 32–82 (60)
Gender # (%)
 Male 18 (85.7)
 Female 3 (14.3)
Prior treatment # (%)
 Surgery 20 (95.2)
 Radiation 20 (95.2)
Primary tumor # (%)
 Lumbar/sacral spine 14 (66.7)
 Clivus 6 (28.6)
 Cervical spine 1 (4.8)
Metastatic disease at baseline # (%)
 Yes 14 (66.7)
 No 7 (33.3)